Blog

The Impact of Dr. Satya Vadlamani’s Leadership on Murli Krishna Pharma

2024-08-10T01:25:03+05:30

Dr. Satya Vadlamani, CMD of Murli Krishna Pharma Pvt. Ltd. (MKPPL), has reshaped the pharmaceutical landscape in India with her unwavering dedication and strategic acumen. Armed with a degree in Electrical and Electronics Engineering, Ph.D and MBA in Strategic Management, and nearly three decades of experience in global pharmaceutical marketing, Dr. Vadlamani has propelled MKPPL to the forefront of the industry. 

The Impact of Dr. Satya Vadlamani’s Leadership on Murli Krishna Pharma2024-08-10T01:25:03+05:30

Murli Krishna Pharma: Vision & Mission for Anemia Mukt Bharat

2024-08-10T01:25:37+05:30

Murli Krishna Pharma Pvt. Ltd., a leading pharmaceutical company in India, has set its sights on a noble mission: to contribute to the eradication of anemia in the country. With its innovative solutions and unwavering commitment to quality, Murli Krishna Pharma is poised to play a significant role in the government's "Anemia Mukt Bharat" initiative.

Murli Krishna Pharma: Vision & Mission for Anemia Mukt Bharat2024-08-10T01:25:37+05:30

How Murli Krishna Pharma is Redefining Pharmaceutical Standards in India

2024-08-10T01:26:07+05:30

Murli Krishna Pharma Pvt. Ltd. excels in offering a diverse range of Pre-Finished Formulation Intermediates (PFI) and finished dosage forms that adhere to the highest quality standards. The company's PFI product range includes pellets and micro pellets designed for various formulations like capsules, injectables, tablets, and suspensions. These products come in different percentages, mesh sizes, and release types, catering to a wide array of medical needs.

How Murli Krishna Pharma is Redefining Pharmaceutical Standards in India2024-08-10T01:26:07+05:30

Murli Krishna Pharma’s Mission to End Anemia’s Grip on Indian Communities

2024-08-10T01:26:41+05:30

Anemia is a significant public health challenge in Indian communities, disproportionately affecting women and children. Murli Krishna Pharma's transdermal lotion offers a unique and non-invasive approach to combating iron deficiency anemia.

Murli Krishna Pharma’s Mission to End Anemia’s Grip on Indian Communities2024-08-10T01:26:41+05:30

Satya – A Woman of Substance

2024-05-19T02:28:47+05:30

The Satya Vadlamani Story illuminates the remarkable trajectory of an extraordinary entrepreneur whose indomitable spirit and unwavering determination propelled her from humble beginnings to the zenith of success. Dr. Satya Vadlamani’s narrative transcends the conventional bounds of entrepreneurship, offering readers an intimate glimpse into the trials, triumphs, and transformative moments that shaped her illustrious career.

Satya – A Woman of Substance2024-05-19T02:28:47+05:30

Murli Krishna Pharma, featured in ZEE TV APAC – Greatest Brands & Leaders 2023 – 2024

2024-08-31T16:12:06+05:30

https://youtu.be/3Iy_MBPsZs4 AsiaOne Magazine presents the 68th episode series of Greatest Brands & Leaders 2023-24 Asia, Americas, Europe and Africa.

Murli Krishna Pharma, featured in ZEE TV APAC – Greatest Brands & Leaders 2023 – 20242024-08-31T16:12:06+05:30

Oral Insulin, sub lingual – A product under development at MKPPL

2023-06-20T16:14:25+05:30

Oral insulin, which refers to insulin that is taken by mouth rather than being injected, has been a subject of research and development for many years. We at MKPPL are working on a sub lingual formulation. Our product so far is stable and is based on human insulin and is long lasting. While there have been challenges in developing an effective oral insulin formulation, if successfully developed, oral insulin could offer several benefits.

Oral Insulin, sub lingual – A product under development at MKPPL2023-06-20T16:14:25+05:30
Go to Top